Title: Full Text of SB2185
Official Title: 
Number of Sections: 1
Source: versions - Senate Amendment 002
Media Type: text/html

================================================================================

Section 1:
Full Text of SB2185 ILGA.GOV SB2185 - 104th General Assembly Sen. Rachel VenturaFiled: 4/4/2025   10400SB2185sam002LRB104 10818 RLC 24878 a1AMENDMENT TO SENATE BILL 21852    AMENDMENT NO. ______. Amend Senate Bill 2185, AS AMENDED, 3by replacing everything after the enacting clause with the 4following: 5    "Section 5. The Unified Code of Corrections is amended by 6adding Section 3-6-2.1 as follows: 7    (730 ILCS 5/3-6-2.1 new)8    Sec. 3-6-2.1. Medication for opioid use disorder. 9    (a) In this Section:10    "Clinically indicated" means a medical procedure or 11treatment is based upon the treatment provider's medical 12judgment in accordance with the current generally accepted 13standards of care. 14    "Medication-assisted treatment" means the use of U.S. 15Federal Drug Administration-approved medications, in 16combination with counseling and behavioral therapies, to   10400SB2185sam002- 2 -LRB104 10818 RLC 24878 a1provide a whole patient approach to the treatment of substance 2use disorders.3     "Medications for opioid use disorder" means the use of 4U.S. Federal Drug Administration-approved medications to treat 5substance use disorders.6    (b) Within 24 hours of admission to a correctional 7institution or facility, each committed person shall be 8screened for substance use disorders as part of an initial and 9ongoing substance use screening and assessment process. This 10process includes screening and assessment for opioid use 11disorders. The Department shall ensure that all persons under 12its care are assessed for substance use disorder not less than 13once per calendar year.14    (c) A committed person who is admitted to a correctional 15institution or facility while under the medical care of a 16licensed physician, a licensed physician assistant, or a 17licensed nurse practitioner and who is taking medication at 18the time of admission as verified by the individual's pharmacy 19of record, primary care provider, other licensed care 20provider, or a prescription monitoring or information system, 21shall have that medication continued and provided by the 22Department pending an evaluation by a licensed physician, a 23licensed physician assistant, or a licensed nurse practitioner 24and subject to the treatment provider's medical judgment. The 25Department may defer provision of a validly prescribed 26medication in accordance with this subsection if, in the   10400SB2185sam002- 3 -LRB104 10818 RLC 24878 a1judgment of a licensed physician, a licensed physician 2assistant, or a licensed nurse practitioner, continuation of 3the medication is no longer clinically indicated.4    A committed person who is admitted to a correctional 5institution or facility while under the medical care of a 6licensed physician, a licensed physician assistant, or a 7licensed nurse practitioner and who is taking medication for 8an opioid use disorder or participating in medication-assisted 9treatment at the time of admission as verified by the 10individual's pharmacy of record, primary care provider, other 11licensed care provider, or a prescription monitoring or 12information system, shall have the committed person's 13medication continued and provided by the Department pending an 14evaluation by a licensed physician, a licensed physician 15assistant, or a licensed nurse practitioner and subject to the 16treatment provider's medical judgment. The Department may 17defer provision of a validly prescribed medication in 18accordance with this subsection if, in the judgment of a 19licensed physician, a licensed physician assistant, or a 20licensed nurse practitioner, continuation of the medication is 21no longer clinically indicated. An individual participating in 22a medication-assisted treatment program may have counseling 23and behavioral therapies continued to the extent possible.24    If at any time a committed person screens positive as 25having or being at risk for an opioid use disorder, is 26diagnosed with an opioid use disorder or is exhibiting   10400SB2185sam002- 4 -LRB104 10818 RLC 24878 a1symptoms of withdrawal from an opioid use disorder, and 2medication-assisted treatment is clinically indicated by a 3licensed physician, a licensed physician assistant, or a 4licensed nurse practitioner, then the individual may consent 5to commence medications for opioid use disorder, which shall 6be provided by the Department. The committed person shall be 7authorized to receive the medication immediately and for as 8long as clinically indicated.9    No person shall be denied participation in 10medication-assisted treatment based on prior success or 11failure of any medication-assisted treatment program. 12    (d) The licensed practitioner who makes the clinical 13judgment to discontinue the use of medication shall enter the 14reason for the discontinuance to be entered into the committed 15person's medical record, specifically stating the reason for 16discontinuance. The individual shall be provided, both orally 17and in writing, with a specific explanation of the decision to 18discontinue the medication.19    (e) As part of the reentry planning, the Department shall 20commence medications for opioid use disorder prior to an 21individual's release if:22        (1) the individual screens positive as having an 23    opioid use disorder, being at risk for an opioid use 24    disorder, or exhibiting symptoms of withdrawal from an 25    opioid use disorder;26        (2) medication-assisted treatment is clinically   10400SB2185sam002- 5 -LRB104 10818 RLC 24878 a1    indicated by a licensed physician, a licensed physician 2    assistant, or a licensed nurse practitioner; and3        (3) The individual consents to commence medications 4    for opioid use disorder.5    Upon reentry, the Department shall provide an individual 6participating in medication-assisted treatment with a referral 7to a community-based provider who may assist the individual 8with continued medications for opioid use disorder and 9medication-assisted treatment care.".


================================================================================

Raw Text:
Full Text of SB2185 ILGA.GOV SB2185 - 104th General Assembly Sen. Rachel VenturaFiled: 4/4/2025   10400SB2185sam002LRB104 10818 RLC 24878 a1AMENDMENT TO SENATE BILL 21852    AMENDMENT NO. ______. Amend Senate Bill 2185, AS AMENDED, 3by replacing everything after the enacting clause with the 4following: 5    "Section 5. The Unified Code of Corrections is amended by 6adding Section 3-6-2.1 as follows: 7    (730 ILCS 5/3-6-2.1 new)8    Sec. 3-6-2.1. Medication for opioid use disorder. 9    (a) In this Section:10    "Clinically indicated" means a medical procedure or 11treatment is based upon the treatment provider's medical 12judgment in accordance with the current generally accepted 13standards of care. 14    "Medication-assisted treatment" means the use of U.S. 15Federal Drug Administration-approved medications, in 16combination with counseling and behavioral therapies, to   10400SB2185sam002- 2 -LRB104 10818 RLC 24878 a1provide a whole patient approach to the treatment of substance 2use disorders.3     "Medications for opioid use disorder" means the use of 4U.S. Federal Drug Administration-approved medications to treat 5substance use disorders.6    (b) Within 24 hours of admission to a correctional 7institution or facility, each committed person shall be 8screened for substance use disorders as part of an initial and 9ongoing substance use screening and assessment process. This 10process includes screening and assessment for opioid use 11disorders. The Department shall ensure that all persons under 12its care are assessed for substance use disorder not less than 13once per calendar year.14    (c) A committed person who is admitted to a correctional 15institution or facility while under the medical care of a 16licensed physician, a licensed physician assistant, or a 17licensed nurse practitioner and who is taking medication at 18the time of admission as verified by the individual's pharmacy 19of record, primary care provider, other licensed care 20provider, or a prescription monitoring or information system, 21shall have that medication continued and provided by the 22Department pending an evaluation by a licensed physician, a 23licensed physician assistant, or a licensed nurse practitioner 24and subject to the treatment provider's medical judgment. The 25Department may defer provision of a validly prescribed 26medication in accordance with this subsection if, in the   10400SB2185sam002- 3 -LRB104 10818 RLC 24878 a1judgment of a licensed physician, a licensed physician 2assistant, or a licensed nurse practitioner, continuation of 3the medication is no longer clinically indicated.4    A committed person who is admitted to a correctional 5institution or facility while under the medical care of a 6licensed physician, a licensed physician assistant, or a 7licensed nurse practitioner and who is taking medication for 8an opioid use disorder or participating in medication-assisted 9treatment at the time of admission as verified by the 10individual's pharmacy of record, primary care provider, other 11licensed care provider, or a prescription monitoring or 12information system, shall have the committed person's 13medication continued and provided by the Department pending an 14evaluation by a licensed physician, a licensed physician 15assistant, or a licensed nurse practitioner and subject to the 16treatment provider's medical judgment. The Department may 17defer provision of a validly prescribed medication in 18accordance with this subsection if, in the judgment of a 19licensed physician, a licensed physician assistant, or a 20licensed nurse practitioner, continuation of the medication is 21no longer clinically indicated. An individual participating in 22a medication-assisted treatment program may have counseling 23and behavioral therapies continued to the extent possible.24    If at any time a committed person screens positive as 25having or being at risk for an opioid use disorder, is 26diagnosed with an opioid use disorder or is exhibiting   10400SB2185sam002- 4 -LRB104 10818 RLC 24878 a1symptoms of withdrawal from an opioid use disorder, and 2medication-assisted treatment is clinically indicated by a 3licensed physician, a licensed physician assistant, or a 4licensed nurse practitioner, then the individual may consent 5to commence medications for opioid use disorder, which shall 6be provided by the Department. The committed person shall be 7authorized to receive the medication immediately and for as 8long as clinically indicated.9    No person shall be denied participation in 10medication-assisted treatment based on prior success or 11failure of any medication-assisted treatment program. 12    (d) The licensed practitioner who makes the clinical 13judgment to discontinue the use of medication shall enter the 14reason for the discontinuance to be entered into the committed 15person's medical record, specifically stating the reason for 16discontinuance. The individual shall be provided, both orally 17and in writing, with a specific explanation of the decision to 18discontinue the medication.19    (e) As part of the reentry planning, the Department shall 20commence medications for opioid use disorder prior to an 21individual's release if:22        (1) the individual screens positive as having an 23    opioid use disorder, being at risk for an opioid use 24    disorder, or exhibiting symptoms of withdrawal from an 25    opioid use disorder;26        (2) medication-assisted treatment is clinically   10400SB2185sam002- 5 -LRB104 10818 RLC 24878 a1    indicated by a licensed physician, a licensed physician 2    assistant, or a licensed nurse practitioner; and3        (3) The individual consents to commence medications 4    for opioid use disorder.5    Upon reentry, the Department shall provide an individual 6participating in medication-assisted treatment with a referral 7to a community-based provider who may assist the individual 8with continued medications for opioid use disorder and 9medication-assisted treatment care.".